Latest Phenols Stories
LAVAL, Quebec and TARRYTOWN, N.Y., April 24, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Progenics Pharmaceuticals, Inc.
New findings presented at American Association for Cancer Research Annual Meeting SANTA ROSA, Calif., April 21, 2015 /PRNewswire/ -- The botanical extract
Oral Buprenorphine Product Candidates (BuTab, REL-1028) to be Compared with Marketed Sublingual and Intravenous Formulations NEW YORK, April 21, 2015 /PRNewswire/ -- Relmada Therapeutics,
BRUSSELS, April 20, 2015 /PRNewswire/ -- UCB, a global biopharmaceutical company focusing on neurology and immunology treatment and research, is sponsoring a total of 24 data presentations at the 67(th)
Phase 1 study to include additional cohorts with novel product candidate being developed for the treatment of neuropathic pain NEW YORK, April 16, 2015 /PRNewswire/ -- Relmada Therapeutics,
SALT LAKE CITY, April 8, 2015 /PRNewswire/ -- Phoenix PharmaLabs, Inc.
DUBLIN, April 8, 2015 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S.
WAYNE, Pa., April 7, 2015 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing
JUPITER, Fla., April 6, 2015 /PRNewswire/ -- Charleston Laboratories, Inc.
- A serpent whose bite was fabled to produce intense thirst.
More Images (1 images) »